您当前所在的位置:首页 > 产品中心 > 产品信息
Sodium iodoacetate_分子结构_CAS_305-53-3)
点击图片或这里关闭

Sodium iodoacetate

产品号 I2512 公司名称 Sigma Aldrich
CAS号 305-53-3 公司网站 http://www.sigmaaldrich.com
分子式 C2H2INaO2 电 话 1-800-521-8956
分子量 207.93032 传 真
纯 度 ≥98% 电子邮件
保 存 Chembase数据库ID: 103329

产品价格信息

请登录

产品别名

标题
Sodium iodoacetate
IUPAC标准名
sodium 2-iodoacetate
IUPAC传统名
sodium 2-iodoacetate
别名
Iodoacetic acid sodium salt
Iodoacetic acid 钠盐

产品登记号

PubChem SID 24895977
Beilstein号 4009322
EC号 206-165-7
MDL号 MFCD00002686
CAS号 305-53-3

产品性质

线性分子式 ICH2COONa
纯度 ≥98%
熔点 208 °C (dec.)(lit.)
GHS危险品标识 GHS05
GHS危险品标识 GHS06
GHS警示词 Danger
GHS危险声明 H301-H315-H318-H335
欧盟危险性物质标志 有毒(Toxic) 有毒(Toxic) (T)
MSDS下载 下载链接
个人保护装置 Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
GHS警示性声明 P261-P280-P301 + P310-P305 + P351 + P338
RID/ADR UN 2811 6.1/PG 3
危险公开号 25-37/38-41
RTECS编号 AI3675000
安全公开号 26-39-45
保存温度 -20°C
联合国危险货物等级 6.1
联合国危险货物编号 2811
联合国危险货物包装类别(PG) 3
德国WGK号 3

产品详细信息

详细说明 (English)
Packaging
25, 100 g in glass bottle
Application
Reagent for the modification of cysteine residues in proteins. Used in protein sequencing (including by Sanger in sequencing bovine insulin) to prevent oxidation of -SH sidechains.
Reagent for the modification of cysteine residues in proteins. Used to induce animal osteoarthritis model system, which mimics both symptoms and histopathology of the human disease.
Biochem/physiol Actions
Used to induce osteoarthritis-like lesions and functional impairment in rats, for testing of chondroprotective agents and diagnostic imaging techniques.1
详细说明 (简体中文)
包装
25, 100 g in glass bottle
Application
Reagent for the modification of cysteine residues in proteins. Used in protein sequencing (including by Sanger in sequencing bovine insulin) to prevent oxidation of -SH sidechains.
Reagent for the modification of cysteine residues in proteins. Used to induce animal osteoarthritis model system, which mimics both symptoms and histopathology of the human disease.
Biochem/physiol Actions
Used to induce osteoarthritis-like lesions and functional impairment in rats, for testing of chondroprotective agents and diagnostic imaging techniques.1

参考文献